In the article titled “Progression-Free and Overall Survival for Concurrent Nivolumab With Standard Concurrent Chemoradiotherapy in Locally Advanced Stage IIIA–B NSCLC: Results From the European Thoracic Oncology Platform NICOLAS Phase II Trial (European Thoracic Oncology Platform 6–14)” (J Thorac Oncol. 2021;16:278–288), one of the coauthor names was misspelled. Dr. Adrian Gasca-Ruchti should be Adriana Gasca-Ruchti. We sincerely regret the error.

        Linked Article